Gilead Sciences Statement on Report About Remdesivir in China
This article is for subscribers only.
Here is the full text of an emailed statement from Gilead Sciences Inc. after reports that the company’s experimental drug being tested in severe Covid-19 patients failed to show a positive result in a Chinese trial.